secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2026-08-19T20:52:07+00:00
Accession:  0001140361-26-033749
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotech CFO Lars Boesgaard resigns; interim CFO and PIO appointed
---------------------------------------------------------------------

- Lars Boesgaard resigns as CFO, PFO and PAO effective Sept 12, 2026, to pursue other professional endeavors.
- Resignation is not due to any disagreement with Company operations, policies or practices.
- Frank Bedu-Addo, Ph.D. (President & CEO) appointed interim Principal Financial Officer, effective Sept 12, 2026.
- Janetta Trochimiuk (Controller) appointed interim Principal Accounting Officer; salary $279,519.57/yr, no new equity awards.
- Trochimiuk has 25+ years as Controller/CFO; prior Controller at Delcath Systems and other firms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/0001140361-26-033749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/ef20080681_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-033749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer